“…Drug-loaded soft contact lenses (SCLs) are an attractive form of ophthalmic drug delivery in pharmaceutical research ( Pereira-da-Mota et al, 2022 ; Yang and Lockwood, 2022 ) due to the potential for sustained release, improved patient compliance, increased bioavailability, and a reduction in the dose necessary to reach a therapeutic effect. Different methods for incorporating drugs into SCLs exist ( Akbari et al, 2021 ; Ciolino et al, 2016 ; Datta et al, 2022 ; Franco and De Marco, 2021 ; Hewitt et al, 2020 ; Hsu et al, 2015 ; Li et al, 2020 ; Mu et al, 2021 ; Rykowska et al, 2021 ; Silva et al, 2021a ; Silva et al, 2021b ; Xu et al, 2010 ; Zidan et al, 2021 ), such as dip-coating (soaking) ( Guo et al, 2021 ; Liu et al, 2021 ; Maulvi et al, 2022 ; Wei et al, 2021 ) and molecular imprinting ( Chu et al, 2022 ; Malaekeh-Nikouei et al, 2013 ; Raesian et al, 2021 ), but it is difficult to produce personalised doses using these techniques.…”